Moderna gets USFDA Breakthrough Therapy Designation for RSV vaccine Ruchika Sharma1 Feb 2023 4:00 PM ISTmRNA-1345 is an investigational RSV vaccine that consists of a single mRNA sequence encoding for a stabilized prefusion F glycoprotein.
Moderna, CytomX Therapeutics collaborate for mRNA-based conditionally activated therapeutics Ruchika Sharma8 Jan 2023 10:00 AM ISTCambridge: Moderna, Inc. and CytomX Therapeutics, Inc. have announced a collaboration and licensing agreement to create investigational mRNA-based...
Moderna to buy OriCiro Genomics for USD 85 million Ruchika Sharma5 Jan 2023 11:18 AM ISTCambridge: Moderna, Inc. and OriCiro Genomics K.K. have announced they have entered into a definitive agreement through which Moderna will...
Moderna fires back at Pfizer counterclaims in COVID vaccine patent lawsuit Ruchika Sharma24 Dec 2022 12:30 PM ISTModerna asked for an undisclosed amount of money damages from Pfizer COVID-19 vaccines sold since March.
FDA authorizes availability of bivalent COVID-19 vaccines for children six months to 4 years of age Dr. Kamal Kant Kohli10 Dec 2022 7:45 AM ISTUSA: In an amendment to the emergency use authorizations (EUAs) of the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 vaccines, the U.S. Food...
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents Ruchika Sharma6 Dec 2022 1:30 PM ISTPfizer and BioNTech said in their Monday filing that they developed their vaccine independently, calling Moderna's lawsuit "revisionist history" and...
COVID trials improved diversity recruiting, says Moderna Top Scientist Ruchika Sharma3 Dec 2022 4:00 PM ISTNew York: Moderna Inc's top scientist has said that the vaccine maker has learned how to better recruit from diverse populations for its clinical...
Medical Bulletin 26/November/2022 Dr. Nandita Mohan26 Nov 2022 1:00 PM ISTHere are the top medical news for the day:Risk of severe asthma attacks doubled after Covid-19 restrictions liftedAdults with asthma had, at one...
Pfizer-BioNTech COVID booster targeting Omicron BA.4/5 approved in Britain Ruchika Sharma10 Nov 2022 10:00 AM ISTThe regulator on Wednesday also approved Novavax's COVID-19 shot as a booster for adults.
Moderna gets Health Canada authorization for second Omicron -targeting Bivalent booster Ruchika Sharma6 Nov 2022 4:30 PM ISTCambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced Health Canada has...
Moderna COVID vaccine sales forecasts fall short for 2022, 2023 Ruchika Sharma6 Nov 2022 10:00 AM ISTCambridge: Moderna Inc has cut its 2022 COVID-19 vaccine sales forecast, citing regulatory and production delays, and issued a 2023 outlook...
Merck to develop personalized cancer vaccine in collaboration with Moderna Ruchika Sharma13 Oct 2022 12:15 PM ISTUnder the agreement, originally established in 2016 and amended in 2018, Merck will pay Moderna $250 million to exercise its option for personalized...
